KRYS vs XPEV · P/E 46, rev $235.6M vs rev $895.7M
Krystal Biotech Inc (KRYS) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the KRYS and XPEV stock pages for the full models.
Not investment advice.